Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: In ineffective erythropoiesis, hepcidin synthesis is suppressed by erythroid regulators, namely erythroferrone and growth differentiation factor-15. For the first time, the hypothesis that iron overload in megaloblastic anemia may be related to ineffective erythropoiesis is explored by describing the kinetics of hepcidin, erythroferrone, and growth differentiation factor-15 levels in a patient diagnosed with megaloblastic anemia associated with iron overload.
Case Presentation: An 81-year-old Caucasian male was admitted for fatigue. He had type-2 diabetes previously treated with metformin, ischemic cardiac insufficiency, and stage-3 chronic kidney disease. Vitiligo was observed on both hands. Biological tests revealed normocytic non-regenerative anemia associated with hemolysis, thrombocytopenia, and elevated sideremia, ferritin, and transferrin saturation levels. Megaloblastic anemia was confirmed with undetectable blood vitamin B12 and typical cytological findings like hyper-segmented neutrophils in blood and megaloblasts in bone marrow. The patient received vitamin B12 supplementation. At 3 months, biological parameters reached normal values. Hepcidin kinetics from diagnosis to 3 months inversely correlated with those of erythroferrone and growth differentiation factor-15.
Conclusions: This case suggests that iron-overload mechanisms of dyserythropoietic anemias may apply to megaloblastic anemias.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451118 | PMC |
| http://dx.doi.org/10.1186/s13256-021-03065-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Iron-Loading Anemias.
Adv Exp Med Biol
July 2025
The Tisch Cancer Institute, Division of Hematology and Medical Oncology, Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Erythropoiesis is a process by which red blood cells (RBCs) are produced in the adult bone marrow. It involves the differentiation of erythroid progenitor cells into mature RBCs, which transport oxygen from the lungs to all cells in the body. Erythropoiesis is a complex process with a nuanced crosstalk of regulation involving hormones, cytokines, and growth factors.
View Article and Find Full Text PDFSystemic Iron Metabolism.
Adv Exp Med Biol
July 2025
Center for Iron Disorders, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Iron, a versatile electron donor and acceptor, is essential for life as a component of enzymes and oxygen transporters but also has the potential to cause toxicity when in excess. Its dietary absorption as well as plasma and tissue concentrations are subject to close regulation, systemically coordinated by the interaction of the hepatic peptide hormone hepcidin and its cellular receptor, the iron exporter ferroportin. Ferroportin mediates the delivery of iron to plasma from absorptive enterocytes, from macrophages that digest senescent erythrocytes, and from iron-storing hepatocytes.
View Article and Find Full Text PDFPreterm Piglets Born by Cesarean Section as a Suitable Animal Model for the Study of Iron Metabolism in Premature Infants.
Int J Mol Sci
October 2024
Laboratory of Iron Molecular Biology, Department of Molecular Biology, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, 05-552 Jastrzębiec, Poland.
Article Synopsis
- Preterm infants are highly susceptible to iron deficiency, but understanding of their iron regulation is limited.
- The research aimed to create a suitable animal model by inducing prematurity in piglets, allowing assessment of iron status similar to that of preterm human infants.
- Findings showed that preterm piglets had lower body weight and plasma iron but higher tissue iron and levels of iron-regulatory hormones, indicating a unique pattern of iron metabolism that suggests functional iron deficiency and accumulation.
The drug-specific properties of hypoxia-inducible factor-prolyl hydroxylase inhibitors in mice reveal a significant contribution of the kidney compared to the liver to erythropoietin induction.
Life Sci
June 2024
Applied Oxygen Physiology Project, New Industry Creation Hatchery Center, Tohoku University, Seiryo-machi 2-1, Aoba-ku, Sendai, Miyagi 980-8575, Japan; Division of Oxygen Biology, Tohoku University Graduate School of Medicine, Seiryo-machi 2-1, Aoba-ku, Sendai, Miyagi 980-8575, Japan. Electronic add
Article Synopsis
- Kidney disease leads to anemia mainly due to reduced production of erythropoietin (EPO), which is regulated by hypoxia-inducible transcription factors (HIFs); HIF-PH inhibitors help reactivate EPO production in renal anemia patients.
- This study found that different HIF-PH inhibitors, when administered to mice, can specifically alter EPO gene expression in the kidney and liver, each with unique drug characteristics affecting pharmacokinetics and iron metabolism.
- The findings highlight that targeting renal EPO induction is crucial for the effectiveness of HIF-PH inhibitors, offering insights for choosing the right treatment for individual renal anemia patients.
Characterization of erythroferrone oligomerization and its impact on BMP antagonism.
J Biol Chem
January 2024
Department of Molecular and Cellular Biosciences, University of Cincinnati, Cincinnati, Ohio, USA. Electronic address:
Hepcidin, a peptide hormone that negatively regulates iron metabolism, is expressed by bone morphogenetic protein (BMP) signaling. Erythroferrone (ERFE) is an extracellular protein that binds and inhibits BMP ligands, thus positively regulating iron import by indirectly suppressing hepcidin. This allows for rapid erythrocyte regeneration after blood loss.
View Article and Find Full Text PDF